Article
The novel lncRNA p4516 acts as a prognostic biomarker promoting gastric cancer cell…
Cancer Management and Research · 2019 · Nie ML, Han J, Huang HC, Guo T, Huangfu LT, Cheng XJ, Li XM, Du H, Li QD, Wen XZ, Ji JF
Key facts
| Title | The novel lncRNA p4516 acts as a prognostic biomarker promoting gastric cancer cell proliferation and metastasis |
|---|---|
| First author | Nie ML, Han J, Huang HC, Guo T, Huangfu LT, Cheng XJ, Li XM, Du H, Li QD, Wen XZ, Ji JF |
| Journal | Cancer Management and Research |
| Published | Jun 12, 2019 |
| DOI | 10.2147/CMAR.S201793 |
| Devices mentioned | BK110039, DEN000008, K022086, K103302, K800552, K853723, K860811, K862004, K874160, K874609, K912581, K915561 and 14 more |
| Product codes mentioned | EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, KKX, NDS, PCA and 6 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1